by Elizabeth Hauxwell | Nov 16, 2023 | Uncategorized
MOIC applied for funding under the Trust’s Health, Wellbeing and Inclusion programme promoting team building and we were delighted to be successful.
The team spent the day at Colin Glen. Enjoying the facilities on offer, this included a Zip Wire of 250m, The Bull Run, lunch and The Health & Wellbeing trail. The Trust aim it not only to support the community and service users’ health & wellbeing, but also to support staff health and wellbeing. The recently updated Staff Health, Wellbeing and Inclusion Strategy continues to focus on your mental, emotional and physical wellbeing.
by Edel O'Sullivan, | May 11, 2023 | News Release, Press, Uncategorized
MOIC have always focused on building collaborations throughout Europe and we have put Northern Ireland firmly on the map as a centre of excellence for pharmacy.
Over the last 20 years we have developed a world class hospital pharmacy service and our focus on medicine management has been replicated throughout the world. Due to this success we are delighted that Professor Mike Scott will present virtually today to a group of hospital pharmacies in South East Norway on the development of medicines management and medicines optimisation in Northern Ireland. Professor Scott will also discuss our work on the Isimpathy project and showcase how this pharmacy project has improved care for patients prescribed with multiple medicines.
The discussion in Norway follows on from a visit by a group of pharmacists from Norway in 2019 to MOIC, when they were impressed by the work of MOIC and the pharmacy practices in Northern Ireland.
by Edel O'Sullivan, | Apr 27, 2023 | News Release, Press, Uncategorized
The latest edition of the MOIC Newsletter is now available.
This includes updates from March and April 2023. We have now added a “Upcoming Conferences and Events” section outlining conferences that we will be presenting and exhibiting at over the next few months.
View our Newsletter.
by Edel O'Sullivan, | Mar 23, 2023 | News Release, Press, Uncategorized
MOIC Project Managers Rachel Huey and Catherine Goudy attended the European Association of Hospital Pharmacists Congress in Lisbon this week and contributed to the poster display.
The poster contribution looked at the technical assessment of PPE during COVID-19. MOIC alongside the Business Services Organisation Procurement and Logistics Services (BSOPaLS) and regional Infection Prevention and Control colleagues utilised pharmacist skills to develop a technical process that was used right across Northern Ireland in response to the COVID-19 pandemic and escalating demand for PPE.
You can view the poster here: MOIC poster EAHP Congress
by Edel O'Sullivan, | Jan 26, 2023 | News Release, Press, Uncategorized
Permanent Secretary Peter May recently visited MOIC and met with Director Professor Mike Scott and Deputy Director Dr. Glenda Fleming.
Also in attendance was Northern Trust Chief Executive Jennifer Welsh and Chief Pharmaceutical Officer Cathy Harrison.
We discussed how MOIC are improving patient outcomes in Northern Ireland through better medicine use and are building collaborations throughout Europe.
by Edel O'Sullivan, | Jan 7, 2022 | News Release, Press, Uncategorized
MOIC are partnering with the Western Health and Social Care Trust Respiratory Services and Continga® to look at innovative ways of monitoring asthma patients medications from their own home through direct observation of therapy (DOT). Direct observation of therapy (DOT) is the visual monitoring of a patient’s medication administration, to ensure compliance or effective technique.
Continga® has developed a video DOT (v-DOT) platform that operates on mobile phones and other portable devices. The process involves the patient making a short ‘selfie’ video of their medication administration, which is automatically uploaded for viewing, on a secure website, by a healthcare professional.
This project aims to use the Continga® v-DOT platform to collect data from 10 patients from the adult asthma service, Altnagelvin Area Hospital. Patients will be invited to use the Continga® v-DOT platform (with their direct clinical care team) for a period of up to 6 weeks. The data from the 10 patients will be collected over a period of three months.
The primary aim of this quality improvement project is to determine the feasibility and establish the use of the Continga® v-DOT platform in the adult asthma patient service in the WHSCT.
The project opened to patients in December. So far two patients have begun their journey using this platform and we will provide further progress updates throughout the project.
